TD-0903

· Theravance Biopharma

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TD-0903, covering 2022-03-17 to 2022-03-17. Get the full timeline:

Most recent: Clinical Trial Update: TD-0903 for ALI Associated With COVID-19 [Phase 2]